Polish Journal of Paediatrics
en POLSKI
eISSN: 2300-8660
ISSN: 0031-3939
Pediatria Polska - Polish Journal of Paediatrics
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2026
vol. 101
 
Share:
Share:
Review paper

Metabolic disruption in early life: the role of endocrine disruptors in pediatric obesity

Jakub Kleinrok
1
,
Weronika Pająk
1
,
Joanna Pec
2
,
Jan Wojtas
2
,
Jacek Baj
2

  1. Department of Forensic Medicine, Medical University of Lublin, Lublin, Poland
  2. Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, Lublin, Poland
Pediatr Pol 2026; 101 (1): 73-80
Online publish date: 2026/03/30
Article file
Get citation
 
PlumX metrics:
 
1. Koziol-Kozakowska A, Cichocka-Mroczek E, Wójcik M. Assessment of nutritional status and the occurrence of complications in children with obesity based on its severity. Pediatr Pol 2025; 100: 135-140.
2. Jebeile H, Kelly AS, O’Malley G, Baur LA. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol 2022; 10: 351-365.
3. Molnár D, Mazur A, Gawlik AM, Telega G, Vlachopapadopoulou E, Wojcik M. Editorial: endocrine and metabolic consequences of childhood obesity. Front. Endocrinol 2022; 13: 1000597.
4. Amato AA, Wheeler HB, Blumberg B. Obesity and endocrine- disrupting chemicals. Endocr 2021; 10: R87-R105.
5. Pasquali R, Casanueva F, Haluzik M, van Hulsteijn L, Ledoux S, Monteiro MP, et al. European Society of Endocrinology Clinical Practice Guideline: endocrine work-up in obesity. Eur J Endocrinol 2020; 182: G1–G32.
6. Salunke DD, Aher AA, Thitame SN. Endocrine disorder: advance in understanding diabetes and obesity a review. J Pharm Bioallied Sci 2025; 17: S32-S35.
7. Lauretta R, Sansone A, Sansone M, Romanelli F, Appetecchia M. Endocrine disrupting chemicals: effects on endocrine glands. Front Endocrinol (Lausanne) 2019; 10: 178.
8. Di Pietro G, Forcucci F, Chiarelli F. Endocrine disruptor chemicals and children’s health. Int J Mol Sci 2023; 24: 2671.
9. Amir S, Shah STA, Mamoulakis C, Docea AO, Kalantzi OI, Zachariou A, et al. Endocrine disruptors acting on estrogen and androgen pathways cause reproductive disorders through multiple mechanisms: a review. Int J Environ Res Public Health 2021; 18: 1464.
10. Ahn C, Jeung EB. Endocrine-disrupting chemicals and disease endpoints. Int J Mol Sci 2023;24: 5342.
11. Guarnotta V, Amodei R, Frasca F, Aversa A, Giordano C. Impact of chemical endocrine disruptors and hormone modulators on the endocrine system. Int J Mol Sci 2022; 23: 5710.
12. Lizunkova P, Engdahl E, Borbély G, Gennings C, Lindh C, Bornehag CG, et al. A mixture of endocrine disrupting chemicals associated with lower birth weight in children induces adipogenesis and DNA methylation changes in human mesenchymal stem cells. Int J Mol Sci 2022; 23: 2320.
13. Maradonna F, Carnevali O. Lipid metabolism alteration by endocrine disruptors in animal models: an overview. Front Endocrinol 2018; 9: 654.
14. Rotondo E, Chiarelli F. Endocrine-disrupting chemicals and insulin resistance in children. Biomedicines 2020; 8: 137.
15. Celik MN, Yesildemir O. Endocrine disruptors in child obesity and related disorders: early critical windows of exposure. Curr Nutr Rep 2025; 14: 14.
16. Fassler CS, Pinney SE, Xie C, Biro FM, Pinney SM. Complex relationships between perfluorooctanoate, body mass index, insulin resistance and serum lipids in young girls. Environ Res 2019; 176: 108558.
17. Choi YJ, Lee YA, Hong YC, Gho J, Lee KS, Shin CH, et al. Effect of prenatal bisphenol A exposure on early childhood body mass index through epigenetic influence on the insulin-like growth factor 2 receptor (IGF2R) gene. Environ Int 2020; 143: 105929.
18. Shin MW, Kim SH. Hidden link between endocrine-disrupting chemicals and pediatric obesity. Clin Exp Pediatr 2025; 68: 199-222.
19. Guarnotta V, Amodei R, Frasca F, Aversa A, Giordano C. Impact of chemical endocrine disruptors and hormone modulators on the endocrine system. Int J Mol Sci 2022; 23: 5710.
20. Leemans M, Couderq S, Demeneix B, Fini JB. Pesticides with potential thyroid hormone-disrupting effects: a review of recent data. Front Endocrinol (Lausanne) 2019; 10: 743.
21. Predieri B, Iughetti L, Bernasconi S, Street ME. Endocrine disrupting chemicals’ effects in children: what we know and what we need to learn? Int J Mol Sci 2022; 23: 11899.
22. Coperchini F, Croce L, Ricci G, Magri F, Rotondi M, Imbriani M, et al. Thyroid disrupting effects of old and new generation PFAS. Front Endocrinol (Lausanne) 2021; 11: 612320.
23. Yang C, Lee HK, Kong APS, Lim LL, Cai Z, Chung ACK. Early-life exposure to endocrine disrupting chemicals associates with childhood obesity. Ann Pediatr Endocrinol Metab 2018; 23: 182-195.
24. Nettore IC, Franchini F, Palatucci G, Macchia PE, Ungaro P. Epigenetic mechanisms of endocrine-disrupting chemicals in obesity. Biomedicines 2021; 9: 1716.
25. Martinho LCAP. Programming of obesity and pediatric metabolic syndromes: a review in light of epigenetic modulation. Int J Nutrol 2021; 15: .
26. Predieri B, Iughetti L, Bernasconi S, Street ME. Endocrine disrupting chemicals’ effects in children: what we know and what we need to learn? Int J Mol Sci. 2022; 23: 11899.
27. Dalamaga M, Kounatidis D, Tsilingiris D, Vallianou NG, Karampe- la I, Psallida S, et al. The role of endocrine disruptors bisphenols and phthalates in obesity: current evidence, perspectives and controversies. Int. J Mol Sci 2024; 25: 675.
28. Celik MN, Yesildemir O. Endocrine disruptors in child obesity and related disorders: early critical windows of exposure. Curr Nutr Rep 2025; 14: 14.
29. Lauritzen HB, Larose TL, Øien T, Sandanger TM, Odland JØ, van de Bor M, et al. Prenatal exposure to persistent organic pollutants and child overweight/obesity at 5-year follow-up: a prospective cohort study. Environ Health 2018; 17: 9.
30. Stratakis N, Rock S, La Merrill MA, Saez M, Robinson O, Fecht D, et al. Prenatal exposure to persistent organic pollutants and childhood obesity: A systematic review and meta-analysis of human studies. Obes Rev 2022; 23: e13383.
31. Güil-Oumrait N, Stratakis N, Maitre L, Anguita-Ruiz A, Urquiza J, Fabbri L, et al. Prenatal exposure to chemical mixtures and metabolic syndrome risk in children. JAMA Netw Open 2024; 7: e2412040.
32. Shafei AE, Nabih ES, Shehata KA, Abd Elfatah ESM, Sanad ABA, Marey MY, et al. Prenatal exposure to endocrine disruptors and reprogramming of adipogenesis: an early-life risk factor for childhood obesity. Child Obes 2018; 14: 18-25.
33. Jerrold J. Heindel, endocrine disruptors and the obesity epidemic. Toxicol Sci 2003; 76: 247-249,
34. Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol 2017; 68: 3-33.
35. Heindel JJ, Alvarez JA, Atlas E, Cave MC, Chatzi VL, Collier D, et al. Obesogens and obesity: state-of-the-science and future directions summary from a healthy environment and endocrine disruptors strategies workshop. Am J Clin Nutr 2023; 118: 329-337.
36. Lv Y, Jia Z, Wang Y, Huang Y, Li C, Chen X, et al. Prenatal EDC exposure, DNA methylation, and early childhood growth: a prospective birth cohort study. Environ Int 2024; 190: 108872.
37. Le Magueresse-Battistoni B, Labaronne E, Vidal H, Naville D. Endocrine disrupting chemicals in mixture and obesity, diabetes and related metabolic disorders. World J Biol Chem 2017; 8: 108-119.
38. Gupta R, Kumar P, Fahmi N, Garg B, Dutta S, Sachar S, et al. Endocrine disruption and obesity: a current review on environmental obesogens. Curr Res Green Sustainabl Chem 2020; 3: 100009.
39. Greenberg P, Chitnis A, Louie D, Simes, Berman R, Koenigsberg SH, et al. The economic burden of adults with major depressive disorder in the United States (2019). Adv Ther 2023; 40: 4460-4479.
40. Thomas J. The economic burden of morbid obesity: impact onHealthcare systems. J Obes Weight Loss Ther 2024; 14: 727.
41. United Nations Environment Programme (UNEP). Global Outlook on Chemicals and Health. UNEP 2021.
42. Pravednikov A, Perkovic S, Lagerkvist CJ. Main factors influencing the perceived health risk of endocrine-disrupting chemicals: a systematic literature review. Environ Res 2024; 262: 119836.
43. Mie A, Andersen HR, Gunnarsson S, Kahl J, Kesse-Guyot E, Rembiałkowska E, et al. Human health implications of organic food and organic agriculture: a comprehensive review. Environ Health 2017; 16: 111.
44. Kassotis CD, Vandenberg LN, Demeneix BA, Porta M, Slama R, Trasande L. Endocrine-disrupting chemicals: economic, regulatory, and policy implications. Lancet Diabetes Endocrinol 2020; 8: 719-730.
45. Andersson N, Arena M, Auteri D, Barmaz S, Grignard E, Kien- zler A, et al. European Chemical Agency (ECHA) and European Food Safety Authority (EFSA) with the technical support of the Joint Research Centre (JRC); Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009. EFSA J 2018; 16: e05311.
46. Yang C, Lee HK, Kong APS, Lim LL, Cai Z, Chung ACK. Early-life exposure to endocrine disrupting chemicals associates with childhood obesity. Ann Pediatr Endocrinol Metab 2018; 23: 182-195.
47. Tickner JA, Simon RV, Jacobs M, Pollard LD, van Bergen SK. The nexus between alternatives assessment and green chemistry: supporting the development and adoption of safer chemicals. Green Chem Lett Rev 2020; 14: 23-44.
Copyright: © 2026 Polish Society of Paediatrics. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.